pH-Responsive Delivery of Nonsteroidal Anti-Inflammatory Drugs by ZIF-8 Metal-Organic Frameworks for Cancer Treatment
ACS Omega · 03.11.2026 · 11 (43) · 66933-66941
DOI: 10.1021/acsomega.6c06939 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 21.10.2026. Verfasst von Nicola di Nicola und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical and Chemical Sciences (DSFC), University of L'Aquila, via Vetoio ("A.C. De Meis" building), Coppito, L'Aquila 67100, Italy. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NextGenerationEU.
Abstract (Originalsprache)
Nonsteroidal anti-inflammatory drugs (NSAIDs) have attracted increasing attention as potential anticancer agents due to their ability to inhibit cyclooxygenase-mediated inflammatory pathways involved in tumor progression. However, their clinical use in oncology remains limited by poor tumor selectivity and systemic toxicity. In this work, we investigate zeolitic imidazolate framework-8 (ZIF-8) nanoparticles as pH-responsive carriers for the delivery of different NSAIDs with potential anticancer activity. A loading strategy based on the conversion of the drugs into their sodium salts, followed by ultrasound-assisted encapsulation, was developed to preserve the structural integrity of the MOF while achieving efficient drug incorporation. Structural and textural characterization by XRPD, SEM, ATR-MIR spectroscopy, and nitrogen physisorption confirmed the formation of ZIF-8 nanoparticles with an average size of about 150 nm and the successful encapsulation of the drugs within the porous framework. High-performance liquid chromatography revealed drug-loading efficiencies exceeding 80% for selected formulations. Release studies demonstrated a pronounced pH-dependent behavior, with significantly faster drug release under mildly acidic conditions that mimic the tumor microenvironment. The biological activity of selected formulations was evaluated in prostate-derived cell models (BPH, LNCaP, and DU145), revealing enhanced cytotoxicity toward cancer cells under acidic conditions compared to physiological pH. In particular, naproxen@ZIF-8 showed a marked reduction in DU145 cell viability at low concentrations and under mildly acidic conditions. These results highlight the potential of ZIF-8 as a versatile nanoplatform for the controlled and tumor-responsive delivery of anti-inflammatory drugs with an anticancer activity.
Autor:innen und Institutionen
- Department of Physical and Chemical Sciences (DSFC), University of L'Aquila, via Vetoio ("A.C. De Meis" building), Coppito, L'Aquila 67100, Italy.
- Consorzio INSTM UdR L'Aquila, via Vetoio ("A.C. De Meis" building), Coppito, L'Aquila 67100, Italy.
- Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L'Aquila, via Vetoio ("A.C. De Meis" building), Coppito, L'Aquila 67100, Italy.
ORCID-Profile: Alessia Marino, Marcello Crucianelli, Davide Vecchiotti, Andrea Lazzarini
Förderung
- NextGenerationEU
Zitieren
APA
di Nicola, N., Di Vito Nolfi, M., Vetrano, A., Esposito, J., Campitelli, P., Marino, A., Zazzeroni, F., Guidoni, L., Crucianelli, M., Vecchiotti, D., & Lazzarini, A. (2026). pH-Responsive Delivery of Nonsteroidal Anti-Inflammatory Drugs by ZIF-8 Metal-Organic Frameworks for Cancer Treatment. ACS Omega, 11(43), 66933-66941. https://doi.org/10.1021/acsomega.6c06939
Vancouver
di Nicola N, Di Vito Nolfi M, Vetrano A, Esposito J, Campitelli P, Marino A, et al. pH-Responsive Delivery of Nonsteroidal Anti-Inflammatory Drugs by ZIF-8 Metal-Organic Frameworks for Cancer Treatment. ACS Omega. 2026;11(43):66933-66941. doi:10.1021/acsomega.6c06939
BibTeX
@article{diNicola2026,
author = {di Nicola, Nicola and Di Vito Nolfi, Mauro and Vetrano, Alice and Esposito, Jennifer and Campitelli, Patrizio and Marino, Alessia and Zazzeroni, Francesca and Guidoni, Leonardo and Crucianelli, Marcello and Vecchiotti, Davide and Lazzarini, Andrea},
title = {pH-Responsive Delivery of Nonsteroidal Anti-Inflammatory Drugs by ZIF-8 Metal-Organic Frameworks for Cancer Treatment},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {43},
pages = {66933--66941},
doi = {10.1021/acsomega.6c06939}
}
EUVIMED